Mount Sinai’s new fund; DOJ appealed lifting of mask mandate; Amwell expanded to MSK and dermatology
Top Health News Mount Sinai Innovation Partners (MSIP), the commercialization arm of the Mount Sinai Health System in New York, launched i3 Prism, a technology commercialization fund focused on women and Black, Indigenous and people of color (BIPOC) health care innovators. Participating innovators can receive up to $33,000 in funding, based on their work’s milestone achievements, in an effort to … [Read more]